<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Volume-based Response Evaluation with Consensual Lesion Selection" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/volume-based-response-evaluation-with-consensual-lesion-selection/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/volume-based-response-evaluation-with-consensual-lesion-selection/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-01-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Volume-based Response Evaluation with Consensual Lesion Selection" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2015-01-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Volume-based Response Evaluation with Consensual Lesion Selection","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/volume-based-response-evaluation-with-consensual-lesion-selection/"},"url":"https://clinicaltree.github.io/posts/volume-based-response-evaluation-with-consensual-lesion-selection/"}</script><title>Volume-based Response Evaluation with Consensual Lesion Selection | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Volume-based Response Evaluation with Consensual Lesion Selection</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Volume-based Response Evaluation with Consensual Lesion Selection</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1422723600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jan 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Estanislao Oubel PhD</a> </em>, <em> <a href="">Eric Bonnard MD</a> </em>, <em> <a href="">Naoko Sueoka-Aragane MD PhD</a> </em>, <em> <a href="">Naomi Kobayashi MD</a> </em>, <em> <a href="">Colette Charbonnier PhD</a> </em>, <em> <a href="">Junta Yamamichi MSc MPH</a> </em>, <em> <a href="">Hideaki Mizobe MSc</a> </em>, <em> <a href="">Shinya Kimura MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2441 words"> <em>13 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Lesion volume is considered as a promising alternative to Response Evaluation Criteria in Solid Tumors (RECIST) to make tumor measurements more accurate and consistent, which would enable an earlier detection of temporal changes. In this article, we report the results of a pilot study aiming at evaluating the effects of a consensual lesion selection on volume-based response (VBR) assessments.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Eleven patients with lung computed tomography scans acquired at three time points were selected from Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) and proprietary databases. Images were analyzed according to RECIST 1.1 and VBR criteria by three readers working in different geographic locations. Cloud solutions were used to connect readers and carry out a consensus process on the selection of lesions used for computing response. Because there are not currently accepted thresholds for computing VBR, we have applied a set of thresholds based on measurement variability (−35% and +55%). The benefit of this consensus was measured in terms of multiobserver agreement by using Fleiss kappa (κ fleiss ) and corresponding standard errors (SE).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>VBR after consensual selection of target lesions allowed to obtain κ fleiss = 0.85 (SE = 0.091), which increases up to 0.95 (SE = 0.092), if an extra consensus on new lesions is added. As a reference, the agreement when applying RECIST without consensus was κ fleiss = 0.72 (SE = 0.088). These differences were found to be statistically significant according to a z-test.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>An agreement on the selection of lesions allows reducing the inter-reader variability when computing VBR. Cloud solutions showed to be an interesting and feasible strategy for standardizing response evaluations, reducing variability, and increasing consistency of results in multicenter clinical trials.</p><p>According to recent statistics of the World Health Organization, cancer is the leading cause of death worldwide accounting for 8.2 million deaths in 2012 . Lung cancer accounted for 1.6 million deaths (19.4%), which makes it the first cause of cancer death even ahead of liver (9.1%) and stomach (8.8%) cancers. Computed tomography (CT) is currently the standard imaging modality for assessing the response to treatment in patients with solid tumors. In general, the quantification of the response is performed by using Response Evaluation Criteria in Solid Tumors (RECIST) . In summary, this standard establishes the way of measuring lesions and provides a set of thresholds to classify the response into partial response, stable disease, and progressive disease. In the context of this article, the term RECIST refers to its revised version (1.1) .</p><p>Even when RECIST criteria have been broadly adopted in clinical trials, they present some drawbacks that are a source of measurement variability. This is quite inconvenient because the consistency in the production of trial results is necessary for comparison purposes . For example, the lesion size is measured as its longest axial diameter, which is not a robust measure in case of complex lesions and creates problems of accuracy and precision . To cope with this drawback, the use of volume is currently being considered as a promising direction to make tumor measurements more accurate and consistent, which would enable an earlier detection of temporal changes . The benefit of using volume as biomarker has already been reported in the literature ; however, the use of volume also presents some drawbacks like the long segmentation time in case of big lesions (in particular for thin-slice acquisitions) and the lack of accepted thresholds for computing response. Regarding this last point, it is worth mentioning the intensive efforts performed by the Quantitative Imaging Biomarkers Alliance to better understand volumetric biomarkers and their sources of variability. In the context of this article, the term volume-based response (VBR) refers to the response estimated exactly as established by RECIST, except for the use of volume of lesions and volume-specific thresholds instead of diameters. The use of VBR was preferred to names like 3D-RECIST to avoid confusion with the application of RECIST with 3D-extended thresholds and also because currently there is no formal definition of the volumetric version of RECIST.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="data-set"><span class="mr-2">Data Set</span><a href="#data-set" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/0_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/0_1s20S1076633214003729.jpg" alt="Figure 1, Distribution of lesions according to its longest axis diameter (D). (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/1_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/1_1s20S1076633214003729.jpg" alt="Figure 2, Distribution of lesions according to location. LLL, left lower lobe; LUL, left upper lobe; MED, mediastinum; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/2_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/2_1s20S1076633214003729.jpg" alt="Figure 3, Distribution of lesions according to surroundings. JP, juxta-pleural; JV, juxta-vascular; PF, perifissural; SL, solitary lesion. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/3_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/3_1s20S1076633214003729.jpg" alt="Figure 4, Distribution of lesions according to shape. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cloud-based-setup-system"><span class="mr-2">Cloud-based Setup System</span><a href="#cloud-based-setup-system" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>1) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>2) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>3) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>4) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/4_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/4_1s20S1076633214003729.jpg" alt="Figure 5, Architecture of the setup cloud solution showing the different stakeholders involved in the reviewing process. UK, United Kingdom. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/5_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/5_1s20S1076633214003729.jpg" alt="Figure 6, Unified Model Language diagram of the reading process. The sequence part inside the loop corresponds to the consensus process aiming to apply RECIST uniformly. IR, independent reviewer." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="volume-measurement"><span class="mr-2">Volume Measurement</span><a href="#volume-measurement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="response-agreement"><span class="mr-2">Response Agreement</span><a href="#response-agreement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="target-lesions"><span class="mr-2">Target Lesions</span><a href="#target-lesions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="new-lesions"><span class="mr-2">New Lesions</span><a href="#new-lesions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="volume-thresholds"><span class="mr-2">Volume Thresholds</span><a href="#volume-thresholds" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data-analysis"><span class="mr-2">Data Analysis</span><a href="#data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="response-agreement-1"><span class="mr-2">Response Agreement</span><a href="#response-agreement-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Fleiss Kappa and Standard Errors (Between Parentheses) According to Different Types of Consensus and Criteria</p><p>Consensus TL Only Response RECIST VBR TL NL — — X 0.72 (0.808)/SuA 0.76 (0.090)/SuA — — — 0.72 (0.090)/SuA 0.76 (0.090)/SuA X — X 0.72 (0.088)/SuA 0.85 (0.091)/APA X — — 0.72 (0.088)/SuA 0.85 (0.092)/APA X X — 0.81 (0.089)/APA<strong>0.95 (0.093)/APA</strong></p><p>APA, almost perfect; NL, new lesion criteria; RECIST, Response Evaluation Criteria in Solid Tumors; SuA, substantial; TL, target lesion; VBR, volume-based response.</p><p>Consensus on TL, NL, and TL only response has been marked with “X” when they are applied and “—” when they are not. The interpretation of values according to Landis and Koch has been added as follows: slight/fair/moderate/substantial/almost perfect agreement. The highest value is shown in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Reproducibility Coefficient for ln(SLV), ln(ΔSLV BL ), and ln(ΔSLV NADIR ) for Consensual and Nonconsensual Selection of target lesions</p><p>Consensus ln(SLV) ln(ΔSLV BL ) ln(ΔSLV NADIR ) No 2.081 1.167 0.915 Yes 0.593 0.678 0.677</p><p>SLV, sum of lesion volumes; ΔSLV BL , change in SLV with respect to baseline (BL); ΔSLV NADIR , change in SLV with respect to nadir.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="comparison-between-vbr-and-recist"><span class="mr-2">Comparison Between VBR and RECIST</span><a href="#comparison-between-vbr-and-recist" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Contingency Table of Responses Provided by RECIST and VBR*</p><p>VBR* RECIST PR SD PD Total PR 14 15 0 29 SD 0 8 2 10 PD 2 2 23 27 Total 16 25 25 66</p><p>PD, progressive disease; PR, partial response; RECIST, Response Evaluation Criteria in Solid Tumors; SD, stable disease; VBR, volume-based response.</p><p>VBR ∗ was computed after consensus on target lesion and new lesion, whereas RECIST was calculated in the classical way (without consensus).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="number-of-lesions"><span class="mr-2">Number of Lesions</span><a href="#number-of-lesions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Response Agreement (as a Percent of Matches) According to the Number of Lesions Used for Computing Response</p><p>1L 2L 4L DIFF(1-2) DIFF(2-4) 93% 75%<strong>100%</strong> 0% 83%</p><p>1 L/2 L/4L, 1/2/4 lesion(s) chosen by both raters; DIFF(1-2), different number of lesions chosen varying between 1 and 2; DIFF(2-4), different number of lesions chosen varying between 2 and 4.</p><p>The best value is shown in bold.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="recist-compliance"><span class="mr-2">RECIST Compliance</span><a href="#recist-compliance" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/6_1s20S1076633214003729.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VolumebasedResponseEvaluationwithConsensualLesionSelection/6_1s20S1076633214003729.jpg" alt="Figure 7, Differences in assessment of longest axial diameter between readers. The figure shows the slice containing the LAD ( blue line ) and the short axis diameter ( red line ). (a) Reader #1, (b) Reader #2, and (c) independent reviewer. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. 2012.International Agency for Research on Cancer Available from: http://globocan.iarc.fr</p><li><p>2. Therasse P., Arbuck S.G., Eisenhauer E.A., et. al.: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000 Feb; 92: pp. 205-216. Available from: http://jnci.oxfordjournals.org/content/92/3/205.abstract</p><li><p>3. Eisenhauera E.A., Therasse P., Bogaerts J., et. al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009 Jan; 45: pp. 228-247. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19097774</p><li><p>4. Erasmus J.J., Gladish G.W., Broemeling L., et. al.: Interobserver and intraobserver variability in measurement of non–small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003 Jan; 21: pp. 2574-2582. Available from http://jco.ascopubs.org/content/21/13/2574</p><li><p>5. Suzuki C, Jacobsson H, Hatschek T, Torkzad MR, Bodén K, Eriksson-Alm Y, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics [Internet]. [cited 2013 Nov 27];28(2):329–344. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18349443</p><li><p>6. Nishino M., Jagannathan J.P., Ramaiya N.H., et. al.: Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. American Roentgen Ray Society AJR Am J Roentgenol 2010 Aug 23; 195: pp. 281-289. Available from: http://www.ajronline.org/doi/full/10.2214/AJR.09.4110</p><li><p>7. Buckler A.J., Mozley P.D., Schwartz L., et. al.: Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker. Acad Radiol 2010 Jan; 17: pp. 107-115. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19969254</p><li><p>8. Buckler A.J., Mulshine J.L., Gottlieb R., et. al.: The use of volumetric CT as an imaging biomarker in lung cancer. Acad Radiol 2010 Jan 1; 17: pp. 100-106. Available from: http://www.academicradiology.org/article/S1076-6332(09)00574-1/abstract</p><li><p>9. Seyal A.R., Parekh K., Velichko Y.S., et. al.: Tumor growth kinetics versus recist to assess response to locoregional therapy in breast cancer liver metastases. Acad Radiol 2014 May 12; Available from: http://www.ncbi.nlm.nih.gov/pubmed/24833565</p><li><p>10. Mozley P.D., Bendtsen C., Zhao B., et. al.: Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. Transl Oncol 2012 Feb; 5: pp. 19-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22348172</p><li><p>11. Quantitative Imaging Biomarkers Alliance [Internet]. Available from: https://www.rsna.org/QIBA.aspx</p><li><p>12. Khul C.K., Barabasch A., Dirrichs T., et. al.: Target lesion selection as a source of variability of response classification by RECIST 1.1. 2013 ASCO Annual Meeting J Clin Oncol 2013; 31: abstr 11077</p><li><p>13. Zhao B., Lee S.M., Lee H.-J., et. al.: Variability in assessing treatment response: metastatic colorectal cancer as a paradigm. Clin Cancer Res 2014 Jul 1; 20: pp. 3560-3568. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24780294</p><li><p>14. Padhani A.R., Ollivier L.: The RECIST criteria: implications for diagnostic radiologists. Br J Radiol 2001 Nov 1; 74: pp. 983-986. Available from: http://bjr.birjournals.org/content/74/887/983.full</p><li><p>15. Schuetze S.M., Baker L.H., Benjamin R.S., et. al.: Selection of response criteria for clinical trials of sarcoma treatment. Oncologist 2008 Jan 1; 13: pp. 32-40. Available from: http://theoncologist.alphamedpress.org/content/13/suppl_2/32.full</p><li><p>16. Dodd L.E., Korn E.L., Freidlin B., et. al.: Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?. J Clin Oncol 2008 Aug 1; 26: pp. 3791-3796. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2654812&amp;tool=pmcentrez&amp;rendertype=abstract</p><li><p>17. Shamsi K., Patt R.H.: Onsite image evaluations and independent image blinded reads: close cousins or distant relatives?. J Clin Oncol 2009 Apr 20; 27: pp. 2103-2104. author reply 2104–5. Available from http://jco.ascopubs.org/content/27/12/2103</p><li><p>18. Ford R., Schwartz L., Dancey J., et. al.: Lessons learned from independent central review. Eur J Cancer 2009 Jan; 45: pp. 268-274. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19101138</p><li><p>19. Zhang J.J., Chen H., He K., et. al.: Evaluation of blinded independent central review of tumor progression in oncology clinical trials: a meta-analysis. Ther Innov Regul Sci 2012 Sep 7; 47: pp. 167-174. Available from: http://dij.sagepub.com/content/47/2/167.short</p><li><p>20. Dodd L.E., Korn E.L., Freidlin B., et. al.: An audit strategy for progression-free survival. Biometrics 2011 Sep; 67: pp. 1092-1099. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3160504&amp;tool=pmcentrez&amp;rendertype=abstract</p><li><p>21. Amit O., Mannino F., Stone A.M., et. al.: Blinded independent central review of progression in cancer clinical trials: results from a meta-analysis. Eur J Cancer 2011 Aug; 47: pp. 1772-1778. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21429737</p><li><p>22. Armato S.G., Meyer C.R., Mcnitt-Gray M.F., et. al.: The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software. Clin Pharmacol Ther 2008 Oct; 84: pp. 448-456. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18754000</p><li><p>23. Herman G.T., Zheng J., Bucholtz C.A.: Shape-based interpolation. IEEE Comput Graph Appl 1992; 12:</p><li><p>24. Fleiss J.L.: Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: pp. 378-382. Available from: http://content.apa.org/journals/bul/76/5/378</p><li><p>25. Barnhart H.X., Haber M.J., Lin L.I.: An overview on assessing agreement with continuous measurements. J Biopharm Stat 2007 Jan; 17: pp. 529-569. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17613641</p><li><p>26. Royston J.P.: An extension of Shapiro and Wilks W test for normality to large samples. Appl Stat 1982; 31: pp. 115-124.</p><li><p>27. Beaumont H., Labatte J.-M., Souchet S., et. al.: Determination of thresholds for the assessment of response to therapy relying on volume-based tumor burden in pulmonary CT images. ASCO Meet Abstr 2013; 31: pp. e18508. Available from: http://meeting.ascopubs.org/cgi/content/abstract/31/15_suppl/e18508</p><li><p>28. R Development Core Team: R: a language and environment for statistical computing.2013.R Foundation for Statistical Computingpp. 409. Available from: http://www.r-project.org</p><li><p>29. Gamer M.: Package irr.2012. Available from: http://cran.r-project.org/web/packages/irr/</p><li><p>30. Landis J.R., Koch G.G.: The measurement of observer agreement for categorical data. Biometrics 1977 Mar; 33: pp. 159-174. Available from: http://www.ncbi.nlm.nih.gov/pubmed/843571</p><li><p>31. Moskowitz C.S., Jia X., Schwartz L.H., et. al.: A simulation study to evaluate the impact of the number of lesions measured on response assessment. Eur J Cancer 2009 Jan; 45: pp. 300-310. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2652848&amp;tool=pmcentrez&amp;rendertype=abstract</p><li><p>32. Darkeh M.H.S.E., Suzuki C., Torkzad M.R.: The minimum number of target lesions that need to be measured to be representative of the total number of target lesions (according to RECIST). Br J Radiol 2009 Aug; 82: pp. 681-686. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19366735</p><li><p>33. Skougaard K., McCullagh M.J.D., Nielsen D., et. al.: Observer variability in a phase II trial—assessing consistency in RECIST application. Acta Oncol 2012 Jul; 51: pp. 774-780. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22432439</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-2/'>Issue 2</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Volume-based%20Response%20Evaluation%20with%20Consensual%20Lesion%20Selection%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fvolume-based-response-evaluation-with-consensual-lesion-selection%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Volume-based%20Response%20Evaluation%20with%20Consensual%20Lesion%20Selection%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fvolume-based-response-evaluation-with-consensual-lesion-selection%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fvolume-based-response-evaluation-with-consensual-lesion-selection%2F&text=Volume-based%20Response%20Evaluation%20with%20Consensual%20Lesion%20Selection%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessing-the-appropriateness-of-outpatient-abdominopelvic-ct-and-mri-examinations-using-the-america/"><div class="card-body"> <em class="small" data-ts="1422723600" data-df="ll" > Jan 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessing the Appropriateness of Outpatient Abdominopelvic CT and MRI Examinations Using the American College of Radiology Appropriateness Criteria</h3><div class="text-muted small"><p> Rationale and Objectives To retrospectively assess the appropriateness of outpatient abdominal and pelvic computed tomography (CT) and magnetic resonance imaging (MRI) examinations using the Ameri...</p></div></div></a></div><div class="card"> <a href="/posts/automated-breast-segmentation-of-fat-and-water-mr-images-using-dynamic-programming/"><div class="card-body"> <em class="small" data-ts="1422723600" data-df="ll" > Jan 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Breast Segmentation of Fat and Water MR Images Using Dynamic Programming</h3><div class="text-muted small"><p> Rationale and Objectives To develop and test an algorithm that outlines the breast boundaries using information from fat and water magnetic resonance images. Materials and Methods Three algorith...</p></div></div></a></div><div class="card"> <a href="/posts/automated-tissue-segmentation-in-breast-mri/"><div class="card-body"> <em class="small" data-ts="1422723600" data-df="ll" > Jan 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Tissue Segmentation in Breast MRI</h3><div class="text-muted small"><p> Estimating a woman’s risk of breast cancer is becoming increasingly important in clinical practice. As new strategies for breast cancer prevention and risk reduction become available , it is essent...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/visual-search-in-abdominopelvic-ct-interpretation/" class="btn btn-outline-primary" prompt="Older"><p>Visual Search in Abdominopelvic CT Interpretation</p></a> <a href="/posts/when-quality-improvement-fails/" class="btn btn-outline-primary" prompt="Newer"><p>When Quality Improvement Fails</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
